Fundraising Fox

Aperiam Bio

Austin, US · Founded 2021 · Delaware corporation · 4 known investors

aperiambio.com ↗

Aperiam Bio uses computational methods to identify stabilizing mutations in proteins, producing variants with improved expression, solubility, and activity for applications in technical reagents, cosmetics, and pulmonary therapeutics. The company serves partners seeking to manufacture more stable and functional protein-based products across multiple industries.

AI & Machine LearningBiotechDeep Techin /aperiam-bio

Founders & leadership

AC
Austin ColeExecutive Officer, Director

Investors · 4

Civilization Ventures Management, LlcTiburon · $1M – $10M
OMX VenturesLincolnshire
Axial VCreportedSan Francisco · $100K – $5M
KdT VenturesreportedAustin · $500K – $3M

Reported raises · per SEC filings

Form D private placements
▶$4MraisedSep 2023 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Austin ColeExecutive Officer, Director
Amount sold
$4M
Minimum investment
$100K
First sale
Sep 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.7MraisedMar 2022 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Austin ColeExecutive Officer, Director
Amount sold
$3.7M
Minimum investment
$100K
First sale
Jan 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.